Related Experiment Videos
Major vessel arteritis with aortic aneurysm in Behçet's disease
VASA. Zeitschrift Fur Gefasskrankheiten
|January 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
Cell death and differentiation·2004
Early reoperation for perirectal abscess: a preventable complication.
Diseases of the colon and rectum·2001
Mapping a heparin binding site on ErbB-3 epidermal growth factor receptor.
Biochemical and biophysical research communications·2001
Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfaces.
Acta crystallographica. Section D, Biological crystallography·2001
2-Year outcomes of endovascular therapy of popliteal artery restenosis.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Fenestrated TREO® low-profile endograft in hostile access vessels.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Peripheral stent thrombosis: Impact of anticoagulation strategies and diagnostic role of platelet aggregometry.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Lower LDL-c/ApoB ratio is associated with adverse cardiovascular outcomes and advanced peripheral artery disease.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Management of venous thromboembolism in France - a nationwide clinical practice survey among vascular medicine specialists.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Endovascular salvage of distal infrainguinal bypass anastomotic stenosis following thrombectomy using a heparin-bonded covered stent.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Associations of Cholesin and GPR146 with atherosclerotic plaque stability: integrated bioinformatics and functional analyses.
Frontiers in cardiovascular medicine·2026
Caveolin-1 levels associated with coronary artery disease in Chinese participants: a retrospective cohort study.
Frontiers in cardiovascular medicine·2026
PCSK9 inhibitors for lipid-lowering treatment in patients with atherosclerotic cardiovascular disease: a health technology assessment.
Frontiers in cardiovascular medicine·2026